It's time to wrap up our list of 10 stocks under $10. The list was culled from a large grouping of momentum names that have outperformed on a relative-strength basis during the short and intermediate term. The selection was filtered to eliminate any stocks trading above the $10 region, naturally, and then adjusted for other fundamental, technical, and sentiment factors. I hope you've had fun learning about some potential bargains for your portfolio and hearing the stories behind some equities that you've likely not come across in your daily investing research.

The last entry (and these have been in no particular order, by the way) is Allos Therapeutics (NASDAQ: ALTH). The pharmaceutical company is hard at work on technology that improves existing cancer medications. According to Hoovers Online, ALTH's current lead drug candidate -- PDX -- is in trials to combat T-cell lymphoma. Some of the firm's other proposed treatments work to fight solid tumors and lymphoma.

ALTH shares have zoomed higher since mid-September, benefiting from support at their short-term 10-day and 20-day moving averages. During Monday's market pullback, the stock managed a successful retest of its 10-day trendline. It's interesting to note as well that a test of the equity's 20-month moving average in the summer put the shares back in uptrending motion; ALTH has not closed below this trendline since November 2005.


One concern from a contrarian perspective is that covering analysts have already taken a shine to ALTH shares; all five of the brokerage firms following the stock have rated it a "buy" or better, leaving the equity vulnerable to downgrades. Additional broker coverage is also possible as well, however, and this could lift the profile of the outperforming but underappreciated shares.

10 stocks under $10: Bruker BioSciences (BRKR)
10 stocks under $10: TriQuint Semiconductor (TQNT)
10 stocks under $10: CBIZ Inc. (CBZ)
10 stocks under $10: Brigham Exploration (BEXP)
10 Stocks Under $10: Medical Staffing Network Holdings (MRN)
10 Stocks Under $10: Incyte (INCY)
10 Stocks Under $10: Art Technology Group (ARTG)
10 Stocks Under $10: Ampal-American Israel (AMPL)
10 Stocks Under $10: General Moly (GMO)

Beth Gaston Moon is an analyst at Schaeffer's Investment Research.